Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Gevaert

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Clinical and Translational Allergy|March 14, 2012
Diagnostic tools in Rhinology EAACI position paperGlenis Scadding, Peter Hellings, Isam Alobid, et al.
The World Allergy Organization Journal|May 20, 2020
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statementGlenis K Scadding, Peter W Hellings, Claus Bachert, et al.
Frontiers in Allergy|November 18, 2024
Case Report: Dual monoclonal antibody therapy in chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma-a proteome analysisManon Blauwblomme, Philippe Gevaert, Sharon Van Nevel, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2021
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension studyPhilippe Gevaert, Rebecca Saenz, Jonathan Corren, et al.
Science Translational Medicine|October 23, 2024
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosaJozefien Declercq, Sarah Gerlo, Sharon Van Nevel, et al.
Frontiers in Allergy|April 7, 2022
Allergic Rhinitis in Childhood and the New EUFOREA AlgorithmGlenis Kathleen Scadding, Peter Kenneth Smith, Michael Blaiss, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2020
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trialPascal Demoly, Jonathan Corren, Peter Creticos, et al.
Allergy|December 6, 2024
Endotyping in Chronic Rhinosinusitis-An EAACI Task Force ReportSanna Toppila-Salmi, Sietze Reitsma, Valérie Hox, et al.
International Forum of Allergy & Rhinology|November 4, 2025
Mechanisms and Kinetics of Wound Healing in Chronic Rhinosinusitis Patients After Complete Sinus Surgery and Its Improvement by Doxycycline TherapyElke Vandewalle, Els De Schryver, Lien Calus, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2017
Reliable mite-specific IgE testing in nasal secretions by means of allergen microarrayMargot Berings, Stefania Arasi, Natalie De Ruyck, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Clinical and Translational Allergy|March 14, 2012
Diagnostic tools in Rhinology EAACI position paperGlenis Scadding, Peter Hellings, Isam Alobid, et al.
The World Allergy Organization Journal|May 20, 2020
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statementGlenis K Scadding, Peter W Hellings, Claus Bachert, et al.
Frontiers in Allergy|November 18, 2024
Case Report: Dual monoclonal antibody therapy in chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma-a proteome analysisManon Blauwblomme, Philippe Gevaert, Sharon Van Nevel, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2021
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension studyPhilippe Gevaert, Rebecca Saenz, Jonathan Corren, et al.
Science Translational Medicine|October 23, 2024
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosaJozefien Declercq, Sarah Gerlo, Sharon Van Nevel, et al.
Frontiers in Allergy|April 7, 2022
Allergic Rhinitis in Childhood and the New EUFOREA AlgorithmGlenis Kathleen Scadding, Peter Kenneth Smith, Michael Blaiss, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2020
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trialPascal Demoly, Jonathan Corren, Peter Creticos, et al.
Allergy|December 6, 2024
Endotyping in Chronic Rhinosinusitis-An EAACI Task Force ReportSanna Toppila-Salmi, Sietze Reitsma, Valérie Hox, et al.
International Forum of Allergy & Rhinology|November 4, 2025
Mechanisms and Kinetics of Wound Healing in Chronic Rhinosinusitis Patients After Complete Sinus Surgery and Its Improvement by Doxycycline TherapyElke Vandewalle, Els De Schryver, Lien Calus, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2017
Reliable mite-specific IgE testing in nasal secretions by means of allergen microarrayMargot Berings, Stefania Arasi, Natalie De Ruyck, et al.
Pageof 15